Danbury Pharmacal, Inc.; Withdrawal of Approval of 61 Abbreviated New Drug Applications

الملخص

The Food and Drug Administration (FDA) is withdrawing approval of 61 abbreviated new drug applications (ANDA's). Danbury Pharmacal, Inc., notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.